442 related articles for article (PubMed ID: 16370407)
21. Management of irritable bowel syndrome.
Viera AJ; Hoag S; Shaughnessy J
Am Fam Physician; 2002 Nov; 66(10):1867-74. PubMed ID: 12469960
[TBL] [Abstract][Full Text] [Related]
22. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome.
Khoshoo V; Armstead C; Landry L
Aliment Pharmacol Ther; 2006 Jan; 23(1):191-6. PubMed ID: 16393297
[TBL] [Abstract][Full Text] [Related]
23. Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective.
Lewis JH
Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):13-29. PubMed ID: 20136586
[TBL] [Abstract][Full Text] [Related]
24. [Tegaserod in treatment of women with irritable bowel syndrome].
Munck LK; Ainsworth MA
Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
[TBL] [Abstract][Full Text] [Related]
25. Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.
Reilly MC; Barghout V; McBurney CR; Niecko TE
Aliment Pharmacol Ther; 2005 Sep; 22(5):373-80. PubMed ID: 16128674
[TBL] [Abstract][Full Text] [Related]
26. Pharmacologic therapy for the irritable bowel syndrome.
Talley NJ
Am J Gastroenterol; 2003 Apr; 98(4):750-8. PubMed ID: 12738451
[TBL] [Abstract][Full Text] [Related]
27. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
[TBL] [Abstract][Full Text] [Related]
28. Treatment of irritable bowel syndrome. A case control experience.
Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
[TBL] [Abstract][Full Text] [Related]
29. Temporary sacral nerve stimulation for treatment of irritable bowel syndrome: a pilot study.
Lundby L; Krogh K; Buntzen S; Laurberg S
Dis Colon Rectum; 2008 Jul; 51(7):1074-8. PubMed ID: 18418655
[TBL] [Abstract][Full Text] [Related]
30. Overlapping conditions in women with irritable bowel syndrome.
Heitkemper M; Jarrett M
Urol Nurs; 2005 Feb; 25(1):25-30; quiz 31. PubMed ID: 15779689
[TBL] [Abstract][Full Text] [Related]
31. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
Harish K; Hazeena K; Thomas V; Kumar S; Jose T; Narayanan P
J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
[TBL] [Abstract][Full Text] [Related]
32. Common gastrointestinal symptoms: irritable bowel syndrome.
Fashner J; Gitu AC
FP Essent; 2013 Oct; 413():16-23. PubMed ID: 24124703
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of irritable bowel syndrome: state of the art.
Tillisch K; Chang L
Curr Gastroenterol Rep; 2005 Aug; 7(4):249-56. PubMed ID: 16042907
[TBL] [Abstract][Full Text] [Related]
34. Treatment of irritable bowel syndrome: sex and gender specific aspects.
Voß U; Lewerenz A; Nieber K
Handb Exp Pharmacol; 2012; (214):473-97. PubMed ID: 23027463
[TBL] [Abstract][Full Text] [Related]
35. Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation.
Müller-Lissner S; Holtmann G; Rueegg P; Weidinger G; Löffler H
Aliment Pharmacol Ther; 2005 Jan; 21(1):11-20. PubMed ID: 15644040
[TBL] [Abstract][Full Text] [Related]
36. Treatment of irritable bowel syndrome with comorbid anxiety symptoms with mirtazapine.
Spiegel DR; Kolb R
Clin Neuropharmacol; 2011; 34(1):36-8. PubMed ID: 21242743
[TBL] [Abstract][Full Text] [Related]
37. The benefits of loperamide in the treatment of patients with IBS or IBD. Introduction.
Hanauer SB
Rev Gastroenterol Disord; 2007; 7 Suppl 3():S1-2. PubMed ID: 18192960
[No Abstract] [Full Text] [Related]
38. Pharmacological treatment of irritable bowel syndrome--from concept to sales.
Kamm MA
Eur J Surg Suppl; 2002; (587):10-5. PubMed ID: 16144196
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
Chang FY; Lu CL; Chen CY; Luo JC
J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
[TBL] [Abstract][Full Text] [Related]
40. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome.
Giannini EG; Mansi C; Dulbecco P; Savarino V
Nutrition; 2006 Mar; 22(3):334-42. PubMed ID: 16413751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
